Source: Annual Congress 2010 - Special treatment options in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Daghfous, H. Zaibi, O. Kahloul, S. Merai, L. Slim, F. Tritar (Ariana, Tunisia). Primary multidrug-resistant tuberculosis: Serious and expensive disease. Eur Respir J 2010; 36: Suppl. 54, 3131

Member's Comments

No comment yet.

Related content which might interest you: Primary multi-drug resistant tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Management and treatment of multidrug-resistant tuberculosis Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 Nonspecific microflora in patients associated with pulmonary multidrug-resistant tuberculosis Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Management of MDR tuberculosis Source: Short video discussion 2021 Year: 2021 Surgical treatment of multidrug-resistant tuberculosis (MDR TB) Source: Eur Respir J 2003; 22: Suppl. 45, 523s Year: 2003 Analysis of multidrug-resistant tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Epidemiology of TB Source: Eur Respir Mon 2012; 58: 14-25 Year: 2012 The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Treatment of TB Source: Eur Respir Mon 2012; 58: 154-166 Year: 2012 Outcome of pulmonary multidrug-resistant tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 419s Year: 2007 Surgical approach to multidrug-resistant pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 323s Year: 2003 Early diagnosis of sub-clinical multidrug-resistant tuberculosis Source: Annual Congress 2003 - The various appearance of resistance Year: 2003 Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM) Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Diagnosis of COPD in patients with multidrug-resistant tuberculosis Source: International Congress 2018 – COPD around the world Year: 2018 Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India Source: Eur Respir J 2012; 39: 956-962 Year: 2012